Order Article Reprints

Wang F, Han Y, Sang W, Wang L, Liang X, Wang L, Xing Q, Guo Y, Zhang J, Zhang L, et al. In Vitro Drug Screening Using iPSC-Derived Cardiomyocytes of a Long QT-Syndrome Patient Carrying KCNQ1 & TRPM4 Dual Mutation: An Experimental Personalized Treatment. Cells. 2022; 11(16):2495. https://doi.org/10.3390/cells11162495

Wang, Feifei, Yafan Han, Wanyue Sang, Lu Wang, Xiaoyan Liang, Liang Wang, Qiang Xing, Yankai Guo, Jianghua Zhang, Ling Zhang, and et al. 2022. "In Vitro Drug Screening Using iPSC-Derived Cardiomyocytes of a Long QT-Syndrome Patient Carrying KCNQ1 & TRPM4 Dual Mutation: An Experimental Personalized Treatment" Cells 11, no. 16: 2495. https://doi.org/10.3390/cells11162495

Wang, F., Han, Y., Sang, W., Wang, L., Liang, X., Wang, L., Xing, Q., Guo, Y., Zhang, J., Zhang, L., Zukela, T., Xiaokereti, J., Lu, Y., Zhou, X., Tang, B., & Li, Y. (2022). In Vitro Drug Screening Using iPSC-Derived Cardiomyocytes of a Long QT-Syndrome Patient Carrying KCNQ1 & TRPM4 Dual Mutation: An Experimental Personalized Treatment. Cells, 11(16), 2495. https://doi.org/10.3390/cells11162495